Skip to main content
. 2021 Sep 13;15:17534666211042529. doi: 10.1177/17534666211042529

Table 1.

Distribution of genotypes, alleles and phenotypes (allele carriers, carriage) of investigated MUC5B and DSP variants in the group of IPF patients and healthy control participants.

IPF Healthy controls p valuea
n = 210 n = 205
Sex
 Female 71 (33.8%) 80 (39.0%) 0.333
 Male 139 (66.2%) 125 (61.0%)
Age at diagnosis (years), median, minimum–maximum 70 (52–82) 70 (51–88) 0.270
MUC5B rs35705950
 Genotype TT 10 (4.8%) 5 (2.4%) <0.001
 Genotype GT 106 (50.4%) 38 (18.5%)
 Genotype GG 94 (44.8%) 162 (79.0%)
 Risk Allele T 126 (30.0%) 48 (11.7%) <0.001
 Allele G 294 (70.0%) 362 (88.3%) <0.001
 Carriage T 116 (55.0%) 43 (20.9%) <0.001
 Carriage G 200 (95.2%) 200 (97.6%) 0.200
DSP rs2076295
 Genotype GG 82 (39.0%) 38 (18.5%) <0.001
 Genotype GT 87 (41.4%) 102 (49.8%)
 Genotype TT 41 (19.5%) 65 (31.7%)
 Risk Allele G 251 (59.8%) 178 (43.4%) <0.001
 Allele T 169 (40.2%) 232 (56.6%) <0.001
 Carriage G 169 (80.5%) 140 (68.3%) <0.001
 Carriage T 128 (61.0%) 167 (81.5%) <0.001

IPF, idiopathic pulmonary fibrosis.

The distribution of investigated genotypes complied with the Hardy–Weinberg equilibrium.

a

Statistical significance was tested by chi-square test for categorical variables and by Kruskal–Wallis test for continuous variables.

Statistically significant results (p < 0.050) are shown in bold.